A detailed history of Quadrant Capital Group LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 5,024 shares of EW stock, worth $332,387. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,024
Previous 5,774 12.99%
Holding current value
$332,387
Previous $533,000 37.9%
% of portfolio
0.02%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$59.7 - $93.78 $44,775 - $70,335
-750 Reduced 12.99%
5,024 $331,000
Q2 2024

Aug 12, 2024

BUY
$84.3 - $94.31 $37,007 - $41,402
439 Added 8.23%
5,774 $533,000
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $19,005 - $25,036
262 Added 5.16%
5,335 $509,000
Q4 2023

Feb 08, 2024

SELL
$61.71 - $77.76 $40,728 - $51,321
-660 Reduced 11.51%
5,073 $386,000
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $109,600 - $147,727
-1,582 Reduced 21.63%
5,733 $397,000
Q2 2023

Aug 09, 2023

SELL
$81.41 - $94.33 $1,221 - $1,414
-15 Reduced 0.2%
7,315 $690,000
Q1 2023

May 11, 2023

BUY
$74.26 - $84.51 $128,172 - $145,864
1,726 Added 30.8%
7,330 $606,000
Q4 2022

Feb 10, 2023

SELL
$68.3 - $87.44 $40,638 - $52,026
-595 Reduced 9.6%
5,604 $418,000
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $30,476 - $39,697
370 Added 6.35%
6,199 $512,000
Q2 2022

Aug 09, 2022

BUY
$86.5 - $128.27 $17,646 - $26,167
204 Added 3.63%
5,829 $554,000
Q1 2022

May 06, 2022

BUY
$101.96 - $128.34 $28,650 - $36,063
281 Added 5.26%
5,625 $662,000
Q4 2021

Feb 01, 2022

BUY
$106.37 - $130.68 $7,765 - $9,539
73 Added 1.38%
5,344 $692,000
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $20,273 - $24,181
197 Added 3.88%
5,271 $597,000
Q2 2021

Aug 09, 2021

BUY
$83.84 - $104.76 $23,559 - $29,437
281 Added 5.86%
5,074 $526,000
Q1 2021

May 12, 2021

BUY
$78.68 - $90.67 $27,616 - $31,825
351 Added 7.9%
4,793 $401,000
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $10,323 - $13,137
-144 Reduced 3.14%
4,442 $405,000
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $44,211 - $57,535
658 Added 16.75%
4,586 $366,000
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $77,506 - $103,651
1,347 Added 52.19%
3,928 $271,000
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $45,072 - $69,660
860 Added 49.97%
2,581 $489,000
Q4 2019

Feb 03, 2020

BUY
$71.7 - $82.09 $14,841 - $16,992
207 Added 13.67%
1,721 $382,000
Q3 2019

Oct 24, 2019

BUY
$61.55 - $75.43 $14,156 - $17,348
230 Added 17.91%
1,514 $318,000
Q2 2019

Jul 24, 2019

SELL
$55.74 - $64.41 $20,177 - $23,316
-362 Reduced 21.99%
1,284 $225,000
Q1 2019

Apr 29, 2019

BUY
$47.89 - $64.05 $18,629 - $24,915
389 Added 30.95%
1,646 $301,000
Q4 2018

Jan 17, 2019

BUY
$46.41 - $56.94 $5,615 - $6,889
121 Added 10.65%
1,257 $182,000
Q1 2018

May 10, 2018

BUY
$37.19 - $47.45 $371 - $474
10 Added 0.89%
1,136 $150,000
Q4 2017

Jan 31, 2018

BUY
$33.79 - $39.39 $810 - $945
24 Added 2.18%
1,126 $119,000
Q3 2017

Oct 13, 2017

BUY
$36.29 - $38.83 $508 - $543
14 Added 1.29%
1,102 $115,000
Q2 2017

Aug 15, 2017

BUY
N/A
1,088
1,088 $107,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.